The Key Points

  • Don’t use brand names (Ozempic®, Wegovy®, Mounjaro™, Zepbound™) in marketing unless you offer the FDA-approved versions
  • Don’t use generic names (semaglutide, tirzepatide) if offering compounded versions
  • Even educational content about these medications carries risk
  • Update your website now with compliant terminology

What's Happening?

  • Pharmaceutical companies are filing lawsuits over unauthorized brand name usage
  • FDA has removed some medications from the shortage list, changing compounding rules
  • Google and social media have created stricter advertising policies

The Risks Are Real

Legal Issues:

  • Trademark lawsuits from pharmaceutical companies
  • FDA enforcement for improper marketing of compounded medications
  • Rejected ads on Google (requires LegitScript certification) and social media platforms

Educational Content Risks:

  • Using brand names as SEO tactics while offering alternatives may be considered misleading
  • Even purely informational content can trigger trademark concerns

Safe Marketing Alternatives

Use these terms instead:

  • “Physician-supervised GLP-1 weight management”
  • “Clinician-guided weight loss treatments”
  • “Medical weight management solutions”

What To Do Now

1) Check your website for medication names (including in meta data)

2) Review your ads for non-compliant terms

3) Update content to use safe terminology

4) Consult your legal team about your specific situation

Tell Us Your Plan

graphic explainer of medical practice digital marketing success

Let us know:

  • Which medications you actually offer
  • What your legal team recommends
  • Your preferred compliant language

We’ll quickly update your online presence based on your guidance.